Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer - Takeaways - MDSpire

Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer

  • By

  • Han-bing Xie

  • Bei-bei Zhang

  • Lin Zhao

  • Le Liu

  • Ping-ping Liu

  • Xin Zhang

  • Shi-di Miao

  • Rui-tao Wang

  • Hai-tao Xu

  • November 25, 2025

  • 0 min

Share

  • 1

    Colorectal cancer is the third most common cancer globally, with the liver being the primary site for metastasis.

  • 2

    Prealbumin levels are associated with nutritional status and can predict adverse outcomes in colorectal cancer patients.

  • 3

    This study evaluated 627 patients who underwent curative resection for CRC to determine the predictive value of prealbumin for liver metastases.

  • 4

    Lower prealbumin levels were significantly associated with the occurrence of metachronous liver metastases in both primary and validation cohorts.

  • 5

    Patients with advanced tumor stages and positive lymph node involvement exhibited lower prealbumin levels compared to those without liver metastases.

Original Source(s)

Prealbumin Levels as a Predictor of Subsequent Liver Metastases in Colorectal Cancer

  • by Han-bing Xie, Bei-bei Zhang, Lin Zhao, Le Liu, Ping-ping Liu, Xin Zhang, Shi-di Miao, Rui-tao Wang, Hai-tao Xu

  • November 25, 2025

Related Content

Colorectal Cancer Treatment During Pregnancy

Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. This article follows the case of a 36-year-old woman diagnosed with CRC while pregnant and highlights considerations around CRC diagnosis and cancer treatment during pregnancy.

Colonoscopy-detected high-risk adenomas and their association with alcohol consumption among first-degree relatives: an observational case–control study

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

  • May 12, 2026

  • 7 min